We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo WHX Labs Dubai 2026 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

DAS Srl Exhibits Range of Fully Automated Systems at MEDLAB Middle East 2020

By LabMedica International staff writers
Posted on 06 Feb 2020
Illustration
Illustration
DAS Srl (Lazio, Italy) displayed the AP22 IF BLOT ELITE system and its lineup of standalone instruments at MEDLAB Middle East, one of the world’s major events in the field of medical diagnostics that was held in Dubai World Trade Center and attended by thousands of visitors from over 135 countries.

At this year’s MEDLAB, DAS Srl displayed the AP 22 IF BLOT ELITE fully automated system for ELISA and IFA and BLOT methods which can run two ELISA micro-plates with eight tests on line, 16 IFA slides or 24 BLOT strips. In addition to ELISA and IFA processing (AP22, AP22 IF), it can carry out full automation for the Dot/Western Blot, thanks to the blot module and a camera, starting from sample dilution and dispense, reagent dispense, incubation, strip washing to the dot imaging processing and assessment for each strip.

DAS Srl also exhibited its lineup of standalone instruments, including PLATE READER, an eight channel photometer for sequential and simultaneous reading of micro-plate strips with 96 wells; PLATE WASHER, an automated washer for micro-plates with 96 wells featuring an original and versatile aspirate and dispense system that requires less than 3µl of residue washing liquid; and STRIP READER, a one channel photometer able that can read strips with 8/12 wells or part of them and is a mono and bi-chromatic reading system.

DAS Srl also displayed NEO-BIL Plus, an advanced and innovative version of traditional bilirubinometers for analyzing the 'total bilirubin' through a microcapillary tube without using reagents. It performs precise sample measurement of both bilirubin and interferentials on the same point of the capillary through a special reading system using a small quantity of serum. At MEDLAB 2020, DAS Srl exhibited the HB ANALYZER PLUS, a hemoglobinometer for fast and accurate determination of hemoglobin using the cyanmetahemoglobin method. The HB ANALYZER PLUS immediately displays the direct reading, expressed in concentration (g/l, g/dl, mmol/l).

Related Links:
DAS Srl

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic Hematology Analyzer
DH-800 Series
Clinical Chemistry System
P780

Channels

Molecular Diagnostics

view channel
Image: The Monarch Mag Cell-free DNA (cfDNA) Extraction Kit provides isolation of low-abundance cfDNA from a range of biofluids (Photo courtesy of New England Biolabs)

New Extraction Kit Enables Consistent, Scalable cfDNA Isolation from Multiple Biofluids

Circulating cell-free DNA (cfDNA) found in plasma, serum, urine, and cerebrospinal fluid is typically present at low concentrations and is often highly fragmented, making efficient recovery challenging... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: The innovative classifier can guide treatment for PDAC and other immunotherapy-resistant cancers (Photo courtesy of Adobe Stock))

Single Sample Classifier Predicts Cancer-Associated Fibroblast Subtypes in Patient Samples

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers, in part because of its dense tumor microenvironment that influences how tumors grow and respond to treatment.... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more